Skip to main content

Table 6 CLART and LA: agreement with HC2

From: Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

Genotyping assay Assay+/HC2+ Assay+/HC2- Assay-/HC2+ Assay-/HC2-
401 women with abnormal cytology     
CLART 301 (75%) 10 (2%) 54 (13%) 36 (9%)
LA 315 (79%) 11 (3%) 40 (10%) 35 (9%)
125 women with ≥ CIN2     
CLART 116 (93%) 0 (0%) 7 (6%) 2 (2%)
LA 120 (96%) 0 (0%) 3 (2%) 2 (2%)